Brandon G Busbee

Summary

Publications

  1. ncbi request reprint Incremental cost-effectiveness of initial cataract surgery
    Brandon G Busbee
    Center for Evidence Based Health Care Economics, Wills Eye Hospital, Jefferson Medical College, Philadelphia, PA, USA
    Ophthalmology 109:606-12; discussion 612-3. 2002
  2. doi request reprint Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
    Brandon G Busbee
    Tennessee Retina, Nashville, Tennessee Electronic address
    Ophthalmology 120:1046-56. 2013
  3. ncbi request reprint Cost-effectiveness of ocular interventions
    Brandon G Busbee
    The Center for Evidence Based Health Care Economics, Retina Vascular Unit, Cataract and Primary Eye Care Service, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pennsylvania, USA
    Curr Opin Ophthalmol 14:132-8. 2003
  4. ncbi request reprint Endophthalmitis: a reappraisal of incidence and treatment
    Brandon G Busbee
    Retina Vitreous Associates, Nashville, Tennessee 37203, USA
    Curr Opin Ophthalmol 17:286-91. 2006
  5. ncbi request reprint Cost-utility analysis of cataract surgery in the second eye
    Brandon G Busbee
    Center for Evidence Based Health Care Economics, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pennsylvania, USA
    Ophthalmology 110:2310-7. 2003
  6. ncbi request reprint Advances in knowledge and treatment: an update on endophthalmitis
    Brandon G Busbee
    The Retina Service, New England Eye Center Tufts University and Ophthalmic Consultants of Boston, Boston, Massachusetts, USA
    Curr Opin Ophthalmol 15:232-7. 2004
  7. ncbi request reprint Changing trends in the microbiologic aspects of postcataract endophthalmitis
    Franco M Recchia
    Division of Vitreoretinal Diseases and Surgery, Vanderbilt Eye Institute, Nashville, Tenn 37232, USA
    Arch Ophthalmol 123:341-6. 2005
  8. ncbi request reprint Update on treatment strategies for bleb-associated endophthalmitis
    Brandon G Busbee
    Retina Vitreous Associates, Nashville, Tennessee, USA
    Curr Opin Ophthalmol 16:170-4. 2005
  9. doi request reprint Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%
    Jeffrey S Heier
    Ophthalmic Consultants of Boston, Boston, Massachusetts 02114, USA
    Retina 29:1310-3. 2009
  10. ncbi request reprint Bleb-associated endophthalmitis: clinical characteristics and visual outcomes
    Brandon G Busbee
    Retina Service, New England Eye Center, Boston, USA
    Ophthalmology 111:1495-503; discussion 1503. 2004

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Incremental cost-effectiveness of initial cataract surgery
    Brandon G Busbee
    Center for Evidence Based Health Care Economics, Wills Eye Hospital, Jefferson Medical College, Philadelphia, PA, USA
    Ophthalmology 109:606-12; discussion 612-3. 2002
    ..The purpose of this study was to perform a reference case, cost-utility analysis of initial cataract surgery using the current literature on cataract outcomes and complications...
  2. doi request reprint Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
    Brandon G Busbee
    Tennessee Retina, Nashville, Tennessee Electronic address
    Ophthalmology 120:1046-56. 2013
    ..5 mg and 2.0 mg administered monthly and on an as-needed (PRN) basis in treatment-naïve patients with subfoveal neovascular age-related macular degeneration (wet AMD)...
  3. ncbi request reprint Cost-effectiveness of ocular interventions
    Brandon G Busbee
    The Center for Evidence Based Health Care Economics, Retina Vascular Unit, Cataract and Primary Eye Care Service, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pennsylvania, USA
    Curr Opin Ophthalmol 14:132-8. 2003
    ....
  4. ncbi request reprint Endophthalmitis: a reappraisal of incidence and treatment
    Brandon G Busbee
    Retina Vitreous Associates, Nashville, Tennessee 37203, USA
    Curr Opin Ophthalmol 17:286-91. 2006
    ..The current publications that address either the incidence or treatment of endophthalmitis are reviewed...
  5. ncbi request reprint Cost-utility analysis of cataract surgery in the second eye
    Brandon G Busbee
    Center for Evidence Based Health Care Economics, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pennsylvania, USA
    Ophthalmology 110:2310-7. 2003
    ..To perform a reference case cost-utility analysis of second-eye cataract surgery by using the current literature on cataract outcomes and complications...
  6. ncbi request reprint Advances in knowledge and treatment: an update on endophthalmitis
    Brandon G Busbee
    The Retina Service, New England Eye Center Tufts University and Ophthalmic Consultants of Boston, Boston, Massachusetts, USA
    Curr Opin Ophthalmol 15:232-7. 2004
    ..Because complete elimination of postsurgical endophthalmitis appears unattainable, strategies directed at optimal prevention, diagnosis, and management are constantly pursued...
  7. ncbi request reprint Changing trends in the microbiologic aspects of postcataract endophthalmitis
    Franco M Recchia
    Division of Vitreoretinal Diseases and Surgery, Vanderbilt Eye Institute, Nashville, Tenn 37232, USA
    Arch Ophthalmol 123:341-6. 2005
    ..To analyze the microbiologic spectrum and in vitro susceptibility profiles over the last 11 years of organisms isolated from the vitreous of patients with endophthalmitis following cataract surgery...
  8. ncbi request reprint Update on treatment strategies for bleb-associated endophthalmitis
    Brandon G Busbee
    Retina Vitreous Associates, Nashville, Tennessee, USA
    Curr Opin Ophthalmol 16:170-4. 2005
    ..In this article, established findings are compared and potential new treatments that may improve visual outcomes in bleb-associated endophthalmitis are evaluated...
  9. doi request reprint Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%
    Jeffrey S Heier
    Ophthalmic Consultants of Boston, Boston, Massachusetts 02114, USA
    Retina 29:1310-3. 2009
    ..To assess vitreous concentrations of nonsteroidal antiinflammatory drugs (NSAIDs) and prostaglandin E(2) in patients treated with NSAIDs before vitrectomy...
  10. ncbi request reprint Bleb-associated endophthalmitis: clinical characteristics and visual outcomes
    Brandon G Busbee
    Retina Service, New England Eye Center, Boston, USA
    Ophthalmology 111:1495-503; discussion 1503. 2004
    ..To analyze the clinical characteristics and treatment outcomes of patients with bleb-associated endophthalmitis (BAE)...
  11. doi request reprint Overview of ocular anesthesia: past and present
    Juanita S Bryant
    New England Eye Center Boston, Massachusetts, USA
    Curr Opin Ophthalmol 22:180-4. 2011
    ..Many choices of ocular anesthetic techniques are available to the ophthalmologist. This study reviews currently used techniques of topical, subconjunctival and regional block anesthesia used in ophthalmic procedures...
  12. ncbi request reprint CME review: A cost-utility analysis of laser photocoagulation for extrafoveal choroidal neovascularization
    Brandon G Busbee
    Center for Value Based Medicine, and Department of Ophthalmology, Tufts New England Medical Center, USA
    Retina 23:279-87; ; quiz 443-4. 2003
    ....
  13. ncbi request reprint Value-based medicine: a new paradigm to evaluate treatments for vitreoretinal diseases and other medical interventions
    Brandon G Busbee
    Ophthalmic Consultants of Boston, MA 02114, USA
    Int Ophthalmol Clin 44:155-72. 2004